Placebo injection (normal saline)

DRUG5 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), University of Sydney, Garvan Institute of Medical Research, Ege University, Al Mouwasat Hospital

Conditions

CalciphylaxisGonarthrosis; PrimaryHIV InfectionsPremature (Early) EjaculationType 1 Diabetes Mellitus

Phase 1

Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected Adults

CompletedNCT01438606

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Start: 2011-10-31Updated: 2021-10-15

Phase 2

Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes

Not yet recruitingNCT06820281

Garvan Institute of Medical ResearchType 1 Diabetes Mellitus

Start: 2025-12-01End: 2027-12-31Target: 44Updated: 2025-10-08

Phase 3

Better Evidence and Translation for Calciphylaxis

RecruitingNCT05018221

University of SydneyCalciphylaxis

Start: 2021-08-26End: 2029-12-31Target: 350Updated: 2025-08-13

Unknown Phase

Efficacy of Ultrasound-Guided Genicular Nerve Block in Patients With Gonarthrosis: A Randomized, Placebo-Controlled, Double-Blind Study

RecruitingNCT07326098

Ege UniversityGonarthrosis; Primary

Start: 2025-11-01End: 2026-12-01Target: 30Updated: 2026-01-08

Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation

CompletedNCT07426640

Al Mouwasat HospitalPremature (Early) Ejaculation

Start: 2021-11-01End: 2024-11-30Updated: 2026-03-17